loadpatents
Patent applications and USPTO patent grants for Jesudason; Cynthia Darshini.The latest application filed is for "[1,2,4]triazolo derivatives as pde1 inhibitors for the treatment of diabetes".
Patent | Date |
---|---|
[1,2,4]Triazolo derivatives as PDE1 inhibitors for the treatment of diabetes Grant 11,401,274 - Genin , et al. August 2, 2 | 2022-08-02 |
[1,2,4]triazolo Derivatives As Pde1 Inhibitors For The Treatment Of Diabetes App 20210147437 - Genin; Michael James ;   et al. | 2021-05-20 |
Azetidinyloxyphenylpyrrolidine compounds Grant 10,781,202 - Deng , et al. Sept | 2020-09-22 |
Azetidinyloxyphenylpyrrolidine Compounds App 20200002318 - Deng; Gary G. ;   et al. | 2020-01-02 |
PDE1 inhibitor Grant 9,868,741 - Jesudason January 16, 2 | 2018-01-16 |
Azetidinyloxyphenylpyrrolidine Compounds App 20170240532 - Deng; Gary G. ;   et al. | 2017-08-24 |
Pde1 Inhibitor App 20170233396 - JESUDASON; Cynthia Darshini ;   et al. | 2017-08-17 |
Histamine H3 receptor agents, preparation and therapeutic uses Grant 8,178,528 - Hipskind , et al. May 15, 2 | 2012-05-15 |
Histamine H3 receptor agents, preparation and therapeutic uses Grant 8,008,296 - Beavers , et al. August 30, 2 | 2011-08-30 |
Histamine H3 receptor agents, preparation and therapeutic uses Grant 8,008,301 - Beavers , et al. August 30, 2 | 2011-08-30 |
Pyrrolidine derivatives as histamine H3 receptor antagonists Grant 7,951,826 - Beavers , et al. May 31, 2 | 2011-05-31 |
Histamine H3 receptor antagonists, preparation and therapeutic uses Grant 7,902,191 - Beavers , et al. March 8, 2 | 2011-03-08 |
Histamine H3 receptor inhibitors, preparation and therapeutic uses Grant 7,846,950 - Jesudason , et al. December 7, 2 | 2010-12-07 |
Histamine H3 Receptor Agents, Preparation And Therapeutic Uses App 20100160406 - Hipskind; Philip Arthur ;   et al. | 2010-06-24 |
Histamine H3 Receptor Agents, Preparation And Therapeutic Uses App 20100160319 - Beavers; Lisa Selsam ;   et al. | 2010-06-24 |
Histamine H3 receptor agents, preparation and therapeutic uses Grant 7,705,025 - Finley , et al. April 27, 2 | 2010-04-27 |
Histamine H3 receptor agents, preparation and therapeutic uses Grant 7,696,234 - Beavers , et al. April 13, 2 | 2010-04-13 |
Histamine H3 Receptor Agents, Preparation And Therapeutic Uses App 20100048580 - Beavers; Lisa Selsam ;   et al. | 2010-02-25 |
Oxazole derivatives as histamine H3 receptor agents, preparation and therapeutic uses Grant 7,666,871 - Beavers , et al. February 23, 2 | 2010-02-23 |
Histamine H3 Receptor Agents, Preparation and Therapeutic Uses App 20100029608 - FINLEY; Don Richard ;   et al. | 2010-02-04 |
Histamine H3 receptor agents, preparation and therapeutic uses Grant 7,632,857 - Hornback , et al. December 15, 2 | 2009-12-15 |
Histamine H3 Receptor Agents, Preparation And Therapeutic Uses App 20090118254 - Beavers; Lisa Selsam ;   et al. | 2009-05-07 |
Histamine H3 Receptor Agents, Preparation And Therapeutic Uses App 20090048225 - Finley; Don Richard ;   et al. | 2009-02-19 |
Pyrrolidine Derivatives as Histamine H3 Receptor Antagonists App 20080207732 - Beavers; Lisa Selsam ;   et al. | 2008-08-28 |
Histamine H3 Receptor Inhibitors, Preparation and Therapeutic Uses App 20080015235 - Jesudason; Cynthia Darshini ;   et al. | 2008-01-17 |
Histamine H3 Receptor Agents, Preparation And Therapeutic Uses App 20070208024 - Beavers; Lisa Selsam ;   et al. | 2007-09-06 |
Oxazole derivatives as histamine h3 receptor agents,preparation and therapeutic uses App 20070197604 - Beavers; Lisa Selsam ;   et al. | 2007-08-23 |
Histamine h3 receptor antagonists, preparation and therapeutic uses App 20070155754 - Beavers; Lisa Selsam ;   et al. | 2007-07-05 |
2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as .beta..sub.3 agonists Grant 7,214,697 - Jesudason , et al. May 8, 2 | 2007-05-08 |
.beta.3 adrenergic agonists Grant 7,208,505 - Sall , et al. April 24, 2 | 2007-04-24 |
3-Substituted oxindole .beta..sub.3 agonsists Grant 7,122,680 - Jesudason , et al. October 17, 2 | 2006-10-17 |
3-substituted oxindole .beta.3 agonists Grant 7,087,635 - Sall , et al. August 8, 2 | 2006-08-08 |
Histamine h3 receptor antagonists, preparation and therapeutic uses App 20060167046 - Beavers; Lisa Selsam ;   et al. | 2006-07-27 |
Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses App 20060089347 - Gadski; Robert Alan ;   et al. | 2006-04-27 |
2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as .beta..sub.3 agonists Grant 7,009,060 - Jesudason , et al. March 7, 2 | 2006-03-07 |
2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists App 20060014963 - Jesudason; Cynthia Darshini ;   et al. | 2006-01-19 |
3-substituted oxindole .beta.-3 agonists Grant 6,911,463 - Sall , et al. June 28, 2 | 2005-06-28 |
Serotonergic benzofurans Grant 6,881,733 - Briner , et al. April 19, 2 | 2005-04-19 |
Beta 3 adrenergic agonists App 20050080110 - Sall, Daniel Jon ;   et al. | 2005-04-14 |
3-Substituted oxindole beta3 agonists App 20050054713 - Jesudason, Cynthia Darshini ;   et al. | 2005-03-10 |
3-substituted oxindole beta-3 agonists App 20040242668 - Sall, Daniel Jon ;   et al. | 2004-12-02 |
Beta3 adrenergic agonists App 20040242633 - Evers, Britta ;   et al. | 2004-12-02 |
3-Substituted oxindole .beta. 3 agonists Grant 6,825,220 - Jesudason , et al. November 30, 2 | 2004-11-30 |
3-Substituted oxindole beta 3 agonists App 20040097532 - Jesudason, Cynthia Darshini ;   et al. | 2004-05-20 |
.beta.3 adrenergic agonists Grant 6,730,792 - Evers , et al. May 4, 2 | 2004-05-04 |
Beta3 adrenergic agonists App 20030191156 - Evers, Britta ;   et al. | 2003-10-09 |
Selective .beta.3 adrenergic agonist Grant 5,977,154 - Bell , et al. November 2, 1 | 1999-11-02 |
Selective .beta.-3 adrenergic agonists Grant 5,840,738 - Bell , et al. November 24, 1 | 1998-11-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.